Published in J Biol Chem on October 22, 2001
c-Myc regulates transcriptional pause release. Cell (2010) 11.64
Transcriptional amplification in tumor cells with elevated c-Myc. Cell (2012) 8.24
NELF and DSIF cause promoter proximal pausing on the hsp70 promoter in Drosophila. Genes Dev (2003) 3.65
The Yin and Yang of P-TEFb regulation: implications for human immunodeficiency virus gene expression and global control of cell growth and differentiation. Microbiol Mol Biol Rev (2006) 3.44
MYC recruits the TIP60 histone acetyltransferase complex to chromatin. EMBO Rep (2003) 3.24
mSin3A/histone deacetylase 2- and PRMT5-containing Brg1 complex is involved in transcriptional repression of the Myc target gene cad. Mol Cell Biol (2003) 2.72
The Trithorax group protein Lid is a trimethyl histone H3K4 demethylase required for dMyc-induced cell growth. Genes Dev (2007) 2.57
Dynamics of human immunodeficiency virus transcription: P-TEFb phosphorylates RD and dissociates negative effectors from the transactivation response element. Mol Cell Biol (2004) 2.49
CDK-9/cyclin T (P-TEFb) is required in two postinitiation pathways for transcription in the C. elegans embryo. Genes Dev (2002) 2.36
Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles. Nature (2014) 2.33
The Emerging Hallmarks of Cancer Metabolism. Cell Metab (2016) 2.32
The glucocorticoid receptor blocks P-TEFb recruitment by NFkappaB to effect promoter-specific transcriptional repression. Genes Dev (2005) 2.29
Evaluation of myc E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays. Mol Cell Biol (2004) 2.19
MYC, metabolism, cell growth, and tumorigenesis. Cold Spring Harb Perspect Med (2013) 2.19
Mechanisms and models of somatic cell reprogramming. Nat Rev Genet (2013) 2.09
RNA polymerase II accumulation in the promoter-proximal region of the dihydrofolate reductase and gamma-actin genes. Mol Cell Biol (2003) 2.07
TRRAP-dependent and TRRAP-independent transcriptional activation by Myc family oncoproteins. Mol Cell Biol (2002) 1.80
STAGA recruits Mediator to the MYC oncoprotein to stimulate transcription and cell proliferation. Mol Cell Biol (2007) 1.78
Transcription-independent functions of MYC: regulation of translation and DNA replication. Nat Rev Mol Cell Biol (2008) 1.72
Analysis of Myc-induced histone modifications on target chromatin. PLoS One (2008) 1.59
Disentangling the MYC web. Proc Natl Acad Sci U S A (2002) 1.47
Using ChIP-chip technology to reveal common principles of transcriptional repression in normal and cancer cells. Genome Res (2008) 1.45
Whole-genome analysis reveals a strong positional bias of conserved dMyc-dependent E-boxes. Mol Cell Biol (2005) 1.44
CDK9 is constitutively expressed throughout the cell cycle, and its steady-state expression is independent of SKP2. Mol Cell Biol (2003) 1.42
Stress response gene ATF3 is a target of c-myc in serum-induced cell proliferation. EMBO J (2005) 1.41
TRRAP and GCN5 are used by c-Myc to activate RNA polymerase III transcription. Proc Natl Acad Sci U S A (2007) 1.39
Loss of protooncogene c-Myc function impedes G1 phase progression both before and after the restriction point. Mol Biol Cell (2003) 1.34
Transcriptional repression: the dark side of myc. Genes Cancer (2010) 1.34
Recruitment of human cyclin T1 to nuclear bodies through direct interaction with the PML protein. EMBO J (2003) 1.26
Evidence that phosphorylation of the RNA polymerase II carboxyl-terminal repeats is similar in yeast and humans. J Biol Chem (2005) 1.24
c-Myc transformation domain recruits the human STAGA complex and requires TRRAP and GCN5 acetylase activity for transcription activation. J Biol Chem (2003) 1.24
Deep sequencing of MYC DNA-binding sites in Burkitt lymphoma. PLoS One (2011) 1.22
You Don't Muck with MYC. Genes Cancer (2010) 1.20
Taming of the beast: shaping Myc-dependent amplification. Trends Cell Biol (2014) 1.19
MicroRNA-34a modulates c-Myc transcriptional complexes to suppress malignancy in human prostate cancer cells. PLoS One (2012) 1.17
Genome recognition by MYC. Cold Spring Harb Perspect Med (2014) 1.10
Myc interacts genetically with Tip48/Reptin and Tip49/Pontin to control growth and proliferation during Drosophila development. Proc Natl Acad Sci U S A (2005) 1.08
c-Jun homodimers can function as a context-specific coactivator. Mol Cell Biol (2007) 1.08
CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma. Genes Dev (2014) 1.07
MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma. Carcinogenesis (2011) 1.06
New insights into the control of HIV-1 transcription: when Tat meets the 7SK snRNP and super elongation complex (SEC). J Neuroimmune Pharmacol (2011) 1.06
CDK-mediated activation of the SCF(FBXO) (28) ubiquitin ligase promotes MYC-driven transcription and tumourigenesis and predicts poor survival in breast cancer. EMBO Mol Med (2013) 0.99
The human I-mfa domain-containing protein, HIC, interacts with cyclin T1 and modulates P-TEFb-dependent transcription. Mol Cell Biol (2003) 0.98
MYC and transcription elongation. Cold Spring Harb Perspect Med (2014) 0.95
Control of vertebrate development by MYC. Cold Spring Harb Perspect Med (2013) 0.94
The positive transcription elongation factor b is an essential cofactor for the activation of transcription by myocyte enhancer factor 2. J Mol Biol (2008) 0.93
DSIF contributes to transcriptional activation by DNA-binding activators by preventing pausing during transcription elongation. Nucleic Acids Res (2007) 0.92
Kinetic analysis of the interaction of b/HLH/Z transcription factors Myc, Max, and Mad with cognate DNA. Biochemistry (2010) 0.90
CDKN1C negatively regulates RNA polymerase II C-terminal domain phosphorylation in an E2F1-dependent manner. J Biol Chem (2010) 0.90
Sequence specificity incompletely defines the genome-wide occupancy of Myc. Genome Biol (2014) 0.89
c-MYC-induced genomic instability. Cold Spring Harb Perspect Med (2014) 0.89
Optimized chimeras between kinase-inactive mutant Cdk9 and truncated cyclin T1 proteins efficiently inhibit Tat transactivation and human immunodeficiency virus gene expression. J Virol (2002) 0.88
Dynamic cumulative activity of transcription factors as a mechanism of quantitative gene regulation. Genome Biol (2007) 0.88
MYC cofactors: molecular switches controlling diverse biological outcomes. Cold Spring Harb Perspect Med (2014) 0.88
Mediator and post-recruitment regulation of RNA polymerase II. Transcription (2012) 0.87
Regulation of the Aurora-A gene following topoisomerase I inhibition: implication of the Myc transcription factor. Mol Cancer (2010) 0.87
Promoter-binding and repression of PDGFRB by c-Myc are separable activities. Nucleic Acids Res (2004) 0.85
Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine. EMBO J (2017) 0.85
Herpes simplex virus 1 ICP22 inhibits the transcription of viral gene promoters by binding to and blocking the recruitment of P-TEFb. PLoS One (2012) 0.84
Human U2 snRNA genes exhibit a persistently open transcriptional state and promoter disassembly at metaphase. Mol Cell Biol (2008) 0.83
Myc coordinates transcription and translation to enhance transformation and suppress invasiveness. EMBO Rep (2015) 0.82
KDM5 interacts with Foxo to modulate cellular levels of oxidative stress. PLoS Genet (2014) 0.81
Progranulin (granulin/epithelin precursor) and its constituent granulin repeats repress transcription from cellular promoters. J Cell Physiol (2010) 0.80
Pausing for thought: disrupting the early transcription elongation checkpoint leads to developmental defects and tumourigenesis. Bioessays (2013) 0.79
MYC interacts with the human STAGA coactivator complex via multivalent contacts with the GCN5 and TRRAP subunits. Biochim Biophys Acta (2014) 0.79
Inhibition of HIV-1 transcription and replication by a newly identified cyclin T1 splice variant. J Biol Chem (2013) 0.79
CDK9/cyclin complexes modulate endoderm induction by direct interaction with Mix.3/mixer. Dev Dyn (2009) 0.78
Compensatory RNA polymerase 2 loading determines the efficacy and transcriptional selectivity of JQ1 in Myc-driven tumors. Leukemia (2016) 0.77
Inhibition of cyclin dependent kinase 9 by dinaciclib suppresses cyclin B1 expression and tumor growth in triple negative breast cancer. Oncotarget (2016) 0.76
Stimulation of Myc transactivation by the TATA binding protein in promoter-reporter assays. BMC Biochem (2005) 0.76
MYC Deregulation in Primary Human Cancers. Genes (Basel) (2017) 0.75
Haploinsufficiency of the Myc regulator Mtbp extends survival and delays tumor development in aging mice. Aging (Albany NY) (2016) 0.75
Inhibition of c-Myc expression accounts for an increase in the number of multinucleated cells in human cervical epithelial cells. Oncol Lett (2017) 0.75
Similarities and Distinctions of Cancer and Immune Metabolism in Inflammation and Tumors. Cell Metab (2017) 0.75
MYC-Master Regulator of the Cancer Epigenome and Transcriptome. Genes (Basel) (2017) 0.75
Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell (1992) 9.19
Use of chromatin immunoprecipitation to clone novel E2F target promoters. Mol Cell Biol (2001) 5.61
c-Myc target gene specificity is determined by a post-DNAbinding mechanism. Proc Natl Acad Sci U S A (1998) 3.81
A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter. Mol Cell Biol (1993) 3.38
Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter. Genes Dev (1994) 3.27
The HIP1 binding site is required for growth regulation of the dihydrofolate reductase gene promoter. Mol Cell Biol (1992) 3.06
Transcription initiation from the dihydrofolate reductase promoter is positioned by HIP1 binding at the initiation site. Mol Cell Biol (1990) 2.96
Target gene specificity of E2F and pocket protein family members in living cells. Mol Cell Biol (2000) 2.85
Mre11 complex and DNA replication: linkage to E2F and sites of DNA synthesis. Mol Cell Biol (2001) 2.85
Myc versus USF: discrimination at the cad gene is determined by core promoter elements. Mol Cell Biol (1997) 2.62
Synthetic sites for transcription termination and a functional comparison with tryptophan operon termination sites in vitro. Proc Natl Acad Sci U S A (1981) 2.62
Computer-assisted identification of cell cycle-related genes: new targets for E2F transcription factors. J Mol Biol (2001) 2.56
Rho-independent termination: dyad symmetry in DNA causes RNA polymerase to pause during transcription in vitro. Nucleic Acids Res (1981) 2.46
Transcriptional regulation of mouse dihydrofolate reductase in the cell cycle. J Biol Chem (1985) 2.31
Opposite-strand RNAs from the 5' flanking region of the mouse dihydrofolate reductase gene. Proc Natl Acad Sci U S A (1985) 2.30
A model for transcription termination suggested by studies on the trp attenuator in vitro using base analogs. Cell (1980) 2.30
Heterogeneity at the 5' termini of mouse dihydrofolate reductase mRNAs. Evidence for multiple promoter regions. J Biol Chem (1985) 2.29
Introduction to the E2F family: protein structure and gene regulation. Curr Top Microbiol Immunol (1996) 2.24
Coexamination of site-specific transcription factor binding and promoter activity in living cells. Mol Cell Biol (1999) 2.09
An E-box-mediated increase in cad transcription at the G1/S-phase boundary is suppressed by inhibitory c-Myc mutants. Mol Cell Biol (1995) 2.08
Effects of NusA protein on transcription termination in the tryptophan operon of Escherichia coli. Cell (1982) 1.96
In vitro transcription and delimitation of promoter elements of the murine dihydrofolate reductase gene. Mol Cell Biol (1986) 1.64
Direct examination of histone acetylation on Myc target genes using chromatin immunoprecipitation. J Biol Chem (2000) 1.54
Expression profiling and identification of novel genes in hepatocellular carcinomas. Oncogene (2001) 1.50
Murine dihydrofolate reductase transcripts through the cell cycle. Mol Cell Biol (1986) 1.43
Site-specific initiation of transcription by RNA polymerase II. Proc Soc Exp Biol Med (1993) 1.43
E2F-mediated growth regulation requires transcription factor cooperation. J Biol Chem (1997) 1.36
Context-dependent transcriptional regulation. J Biol Chem (1999) 1.36
The HIP1 initiator element plays a role in determining the in vitro requirement of the dihydrofolate reductase gene promoter for the C-terminal domain of RNA polymerase II. Mol Cell Biol (1992) 1.35
The chromatin structure of the dual c-myc promoter P1/P2 is regulated by separate elements. J Biol Chem (2001) 1.32
Start site selection at the TATA-less carbamoyl-phosphate synthase (glutamine-hydrolyzing)/aspartate carbamoyltransferase/dihydroorotase promoter. J Biol Chem (1994) 1.30
Transcriptional regulation of the dihydrofolate reductase gene. Bioessays (1996) 1.29
Position-dependent transcriptional regulation of the murine dihydrofolate reductase promoter by the E2F transactivation domain. Mol Cell Biol (1997) 1.26
Cloning, chromosomal location, and characterization of mouse E2F1. Mol Cell Biol (1994) 1.25
Activation of the murine dihydrofolate reductase promoter by E2F1. A requirement for CBP recruitment. J Biol Chem (1999) 1.23
Exogenous E2F expression is growth inhibitory before, during, and after cellular transformation. Oncogene (2000) 1.14
Ultrastructural features of minute chromosomes in a methotrexate-resistant mouse 3T3 cell line. Proc Natl Acad Sci U S A (1985) 1.14
Identification of target genes of oncogenic transcription factors. Proc Soc Exp Biol Med (1999) 1.07
An inhibitory Raf-1 mutant suppresses expression of a subset of v-raf-activated genes. J Biol Chem (1993) 1.03
ZNF217, a candidate breast cancer oncogene amplified at 20q13, regulates expression of the ErbB3 receptor tyrosine kinase in breast cancer cells. Oncogene (2010) 0.99
Transcriptional regulation of the dihydrofolate reductase/rep-3 locus. Crit Rev Eukaryot Gene Expr (1994) 0.97
Direct recruitment of N-myc to target gene promoters. Mol Carcinog (2000) 0.95
The bidirectionally transcribed dihydrofolate reductase and rep-3a promoters are growth regulated by distinct mechanisms. Cell Growth Differ (1995) 0.94
Identification of a new promoter upstream of the murine dihydrofolate reductase gene. Mol Cell Biol (1989) 0.92
Inappropriate transcription from the 5' end of the murine dihydrofolate reductase gene masks transcriptional regulation. Nucleic Acids Res (1994) 0.90
No effect of loss of E2F1 on liver regeneration or hepatocarcinogenesis in C57BL/6J or C3H/HeJ mice. Mol Carcinog (1999) 0.87
v-Raf activates transcription of growth-responsive promoters via GC-rich sequences that bind the transcription factor Sp1. Cell Growth Differ (1995) 0.86
CAD, a c-Myc target gene, is not deregulated in Burkitt's lymphoma cell lines. Mol Carcinog (2000) 0.86
Strain-dependent differences in DNA synthesis and gene expression in the regenerating livers of CB57BL/6J and C3H/HeJ mice. Mol Carcinog (1995) 0.83
krox 20 messenger RNA and protein expression in the adult central nervous system. Brain Res Mol Brain Res (1992) 0.82
Effects of DNA base analogs on transcription termination at the tryptophan operon attenuator of EScherichia coli. Proc Natl Acad Sci U S A (1982) 0.82
Identification of cis-acting elements that can obviate a requirement for the C-terminal domain of RNA polymerase II. J Biol Chem (1995) 0.80
Identification of the serum-responsive transcription initiation site of the zinc finger gene Krox-20. Mol Cell Biol (1990) 0.79
Heat sensitivity and Sp1 activation of complex formation at the Syrian hamster carbamoyl-phosphate synthase (glutamine-hydrolyzing)/aspartate carbamoyltransferase/dihydroorotase promoter in vitro. J Biol Chem (1992) 0.78
Cell cycle analysis of Krox-20, c-fos, and JE expression in proliferating NIH3T3 fibroblasts. Cell Growth Differ (1991) 0.78
Effects of gentamicin on trypsin, chymotrypsin, and collagenase. J Infect Dis (1978) 0.76
A re-examination of the distributions of octopamine and phenylethanolamine in the aplysia nervous system. J Neurochem (1978) 0.75
Characterization of the 3' untranslated region of mouse E2F1 mRNA. Gene (1998) 0.75